- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2059-0105
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
VaxArray potency assay for rapid assessment of “pandemic” influenza vaccines ; volume:3 ; number:1 ; day:8 ; month:10 ; year:2018 ; pages:1-11 ; date:12.2018
npj vaccines ; 3, Heft 1 (8.10.2018), 1-11, 12.2018
- Creator
-
Byrne-Nash, Rose T.
- Contributor
-
Miller, David F.
Bueter, Katie M.
Gillis, Jacob H.
Kuck, Laura R.
Rowlen, Kathy L.
SpringerLink (Online service)
- DOI
-
10.1038/s41541-018-0080-6
- URN
-
urn:nbn:de:101:1-2018102020390671197643
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Byrne-Nash, Rose T.
- Miller, David F.
- Bueter, Katie M.
- Gillis, Jacob H.
- Kuck, Laura R.
- Rowlen, Kathy L.
- SpringerLink (Online service)
Other Objects (12)
A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
PilVax – a novel peptide delivery platform for the development of mucosal vaccines
Dorothea Meyer-Vax
Anguish and fears about attitude towards Covid-19 vaccines: contrasts between yes and no vax
Development of a potency assay for CD34+ cell-based therapy
Bacillus subtilis spore vaccines displaying protective antigen induce functional antibodies and protective potency
In vitro CAR-T cell killing: validation of the potency assay
Dore Meyer-Vax, engagierte Kunst
Firmen A - Z: Vam - Vax
VAX, VMS : Struktur und Anwendung
Cell membrane array fabrication and assay technology
Innovation and patenting activities of COVID-19 vaccines in WTO members: Analytical review of Medicines Patent Pool (MPP) COVID-19 Vaccines Patent Landscape (VaxPaL)
A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
PilVax – a novel peptide delivery platform for the development of mucosal vaccines
Dorothea Meyer-Vax
Anguish and fears about attitude towards Covid-19 vaccines: contrasts between yes and no vax
Development of a potency assay for CD34+ cell-based therapy
Bacillus subtilis spore vaccines displaying protective antigen induce functional antibodies and protective potency
In vitro CAR-T cell killing: validation of the potency assay
Dore Meyer-Vax, engagierte Kunst
Firmen A - Z: Vam - Vax
VAX, VMS : Struktur und Anwendung
Cell membrane array fabrication and assay technology
Innovation and patenting activities of COVID-19 vaccines in WTO members: Analytical review of Medicines Patent Pool (MPP) COVID-19 Vaccines Patent Landscape (VaxPaL)
A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
PilVax – a novel peptide delivery platform for the development of mucosal vaccines
Dorothea Meyer-Vax
Anguish and fears about attitude towards Covid-19 vaccines: contrasts between yes and no vax
Development of a potency assay for CD34+ cell-based therapy
Bacillus subtilis spore vaccines displaying protective antigen induce functional antibodies and protective potency
In vitro CAR-T cell killing: validation of the potency assay
Dore Meyer-Vax, engagierte Kunst
Firmen A - Z: Vam - Vax
VAX, VMS : Struktur und Anwendung
Cell membrane array fabrication and assay technology